By Associate Professor Julia Lappin

Books

Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London

Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health

Book Chapters

Dazzan P; Morgan K; Lappin J; Fearon P, 2012, 'Neuroimaging and psychosis: Are brain changes in individuals with psychosis neurodevelopmental for some and progressive for others?', in Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, pp. 147 - 154, http://dx.doi.org/10.4324/9780203808771

Laurens K; Hodgins S; Taylor EA; Murray RM, 2011, 'Is earlier intervention for schizophrenia possible? Identifying antecedents of schizophrenia in children aged 9-12 years', in David AS; Kapur S; McGuffin P (ed.), Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, Psychology Press Ltd, Taylor & Francis Press, pp. 19 - 32

Ebmeier KP; Lappin JM, 2002, 'Electromagnetic Stimulation and Affective Disorders<footref rid="foot01">¹</footref>', in Perspectives in Affective Disorders, KARGER, pp. 167 - 177, http://dx.doi.org/10.1159/000066883

Ebmeier KP; Lappin JM, 2001, 'Electromagnetic stimulation in psychiatry', in , pp. 181 - 188, http://dx.doi.org/10.1192/apt.7.3.181

Journal articles

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13817

Bolton P; Davies K; Grattan S; Lappin JM, 2024, 'Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone', Australian and New Zealand Journal of Psychiatry, http://dx.doi.org/10.1177/00048674241240601

Macdonald C; Weatherburn D; Lappin J, 2024, 'Diversion into mental health treatment: a survey of magistrates and treatment plans', Psychiatry, Psychology and Law, http://dx.doi.org/10.1080/13218719.2024.2313985

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times.', Drug Alcohol Depend Rep, 10, pp. 100217, http://dx.doi.org/10.1016/j.dadr.2024.100217

Gott CA; Thomas M; Allan J; Kennedy J; Black Y; Dark F; Lappin JM, 2023, 'Cognitive remediation therapy – implementation and translation into clinical practice in rural and metropolitan New South Wales mental health services', Australasian Psychiatry, 31, pp. 584 - 586, http://dx.doi.org/10.1177/10398562231186125

Pollard R; Fisher HL; Fearon P; Morgan K; Lappin J; Hutchinson G; Doody GA; Jones PB; Murray RM; Morgan C; Dazzan P, 2023, 'Parental bonding style and illness severity in a longitudinal study of individuals with first episode psychosis', Archives of Women's Mental Health, 26, pp. 707 - 711, http://dx.doi.org/10.1007/s00737-023-01351-y

Davies K; Grattan S; Gott C; Ellis R; Lappin JM, 2023, 'The tertiary service for psychosis: Holistic recommendations for people with complex psychosis', Australasian Psychiatry, 31, pp. 591 - 597, http://dx.doi.org/10.1177/10398562231189115

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Talukder SR; Lappin JM; Boland V; McRobbie H; Courtney RJ, 2023, 'Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders', Tobacco Control, 32, pp. 489 - 496, http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Srasuebkul P; Walker AR; Cvejic RC; Trollor JN; Lappin JM; Curtis J; Samaras K; Dean K; Ward PB; Reppermund S, 2023, 'Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage study', Australian and New Zealand Journal of Psychiatry, 57, pp. 844 - 853, http://dx.doi.org/10.1177/00048674221115642

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Foley C; Allan J; Lappin J; Courtney R; Farnbach S; Henderson A; Shakeshaft A, 2023, 'Utilising the Implementation of Integrated Care to Develop a Pragmatic Framework for the Sustained Uptake of Service Innovations (SUSI)', Healthcare (Switzerland), 11, http://dx.doi.org/10.3390/healthcare11121786

Davies K; Courtney RJ; Summersby-Mitchell M; Morell R; Briggs N; Lappin JM, 2023, 'A systematic review of factors associated with sustained smoking abstinence in people experiencing severe mental illness following participation in a smoking intervention', Australian and New Zealand Journal of Psychiatry, 57, pp. 489 - 510, http://dx.doi.org/10.1177/00048674221147206

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Cohn SL; Mohan A; Lappin JM; Curtis J; Scott JG, 2023, 'Anti-N-Methyl-D-Aspartate Receptor Antibody Testing in First-Episode Psychosis: Universal or Targeted Testing', Journal of Neuropsychiatry and Clinical Neurosciences, 35, pp. 98 - 101, http://dx.doi.org/10.1176/appi.neuropsych.21080214

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Darke S; Farrell M; Duflou J; Lappin J, 2023, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, http://dx.doi.org/10.1111/add.16407

Davies K; Gott C; Ferdman A; Lloyd K; Pnevmatikos N; Chase E; Lappin J, 2023, 'Promoting psychological interventions in psychosis: the NSW Tertiary Referral Service for Psychosis', Australian Psychologist, 58, pp. 315 - 320, http://dx.doi.org/10.1080/00050067.2023.2211759

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Lappin JM; Davies K; O'Donnell M; Walpola IC, 2022, 'Underuse of recommended treatments among people living with treatment-resistant psychosis', Frontiers in Psychiatry, 13, http://dx.doi.org/10.3389/fpsyt.2022.987468

O'Dea D; Curtis J; Scully A; Lappin J, 2022, 'A pilot study of a mindfulness informed yoga intervention in young people with psychosis', Early Intervention in Psychiatry, 16, pp. 1036 - 1042, http://dx.doi.org/10.1111/eip.13264

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Lappin J, 2022, 'Clinical Management of Withdrawal Series', Addiction, 117, pp. 517, http://dx.doi.org/10.1111/add.15708

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Lappin JM, 2022, 'Comorbid substance use in psychosis: Someone else’s problem?', Australian and New Zealand Journal of Psychiatry, 56, pp. 5 - 7, http://dx.doi.org/10.1177/00048674211065669

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Campbell G; Darke S; Hall W; Lappin J, 2021, 'Increased barbiturate deaths: an unintended consequence of increased publicity for methods of do-it-yourself euthanasia?', Addiction, 116, pp. 3273 - 3275, http://dx.doi.org/10.1111/add.15573

Wang TY; Fan TT; Lappin JM; Li XD; Zhao YM; Wu P; Shi J; Bao YP; Lu L, 2021, 'Cognitive improvement among abstinent methamphetamine users: A 2-year prospective longitudinal study', American Journal on Addictions, 30, pp. 543 - 551, http://dx.doi.org/10.1111/ajad.13209

Lappin JM; Darke S, 2021, 'Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review', Experimental Neurology, 343, pp. 113793, http://dx.doi.org/10.1016/j.expneurol.2021.113793

Cvejic RC; Srasuebkul P; Walker AR; Reppermund S; Lappin JM; Curtis J; Samaras K; Dean K; Ward P; Trollor JN, 2021, 'The health service contact patterns of people with psychotic and non-psychotic forms of severe mental illness in New South Wales, Australia: A record-linkage study', Australian and New Zealand Journal of Psychiatry, 56, pp. 675 - 685, http://dx.doi.org/10.1177/00048674211031483

Wells R; Murad M; Higgins M; Smith L; Lenette C; Lappin J; Dew A; Boydell K; Bibby H; Cassaniti M; Isaacs D; Raman S; Zwi K; Bibby H, 2021, 'Exploring the intersection of human rights, health, disability and refugee status: An arts-based approach', Australian Journal of Human Rights, 26, pp. 387 - 404, http://dx.doi.org/10.1080/1323238X.2021.1882044

Poon AWC; Lappin JM; Cassidy A; Breckenridge J, 2021, 'Scoping Review of Family Interventions That Support the Physical Health of Caregivers', Research on Social Work Practice, 31, pp. 234 - 243, http://dx.doi.org/10.1177/1049731520974444

Campbell G; Darke S; Zahra E; Duflou J; Shand F; Lappin J, 2021, 'Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study', Clinical toxicology (Philadelphia, Pa.), 59, pp. 224 - 230, http://dx.doi.org/10.1080/15563650.2020.1789653

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Yang R; Curtis J; Jensen C; Levy P; Chown K; Lappin JM, 2021, 'Detection and intervention in emerging youth mental health issues: Outcomes from the first year of the CASPAR service', Early Intervention in Psychiatry, 15, pp. 167 - 173, http://dx.doi.org/10.1111/eip.12956

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Gale-Grant O; Dazzan P; Lappin JM; Donoghue K; Reininghaus U; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Morgan C; Heslin M, 2021, 'Diagnostic stability and outcome after first episode psychosis', Journal of Mental Health, 30, pp. 104 - 112, http://dx.doi.org/10.1080/09638237.2020.1818191

Back to profile page